|
HY-101029-10mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-100mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-25mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-50mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-5mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-1mL
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-139330-10mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-100mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-25mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-5mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-50mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-103309-10mg
|
MedChemexpress LLC
|
ML218 [CAS 1346233-68-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103309-100mg
|
MedChemexpress LLC
|
ML218 [CAS 1346233-68-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103309-5mg
|
MedChemexpress LLC
|
ML218 [CAS 1346233-68-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103309-50mg
|
MedChemexpress LLC
|
ML218 [CAS 1346233-68-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103309-1mL
|
MedChemexpress LLC
|
ML218 [CAS 1346233-68-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
sc-485941
|
Santa Cruz Biotechnology
|
1-Nitro-2-naphthol [CAS 550-60-7]
|
|
|
|
|
sc-207284
|
Santa Cruz Biotechnology
|
Amopyroquine [CAS 550-81-2]
|
|
|
|
|
sc-358844
|
Santa Cruz Biotechnology
|
YM 750 [CAS 138046-43-2]
|
|
|
|
|
sc-358844A
|
Santa Cruz Biotechnology
|
YM 750 [CAS 138046-43-2]
|
|
|
|
